Etomidate reduces glutamate uptake in rat cultured glial cells: Involvement of PKA

British Journal of Pharmacology

Volumn 155, Issue 6, 2008, Pages 925-933

  Rath M ^a   Fohr K J ^a   Weigt, H U ^b   Gauss, A ^a   Engele, J ^c   Georgieff, M ^a   Koster S ^d   Adolph, O ^a  

^a UNIVERSITY HOSPITAL ULM   (Germany)

^b SLK Kliniken Heilbronn   (Germany)

^c UNIVERSITY OF LEIPZIG   (Germany)

^d HARVARD UNIVERSITY   (United States)

Author keywords

Epilepsy; Etomidate; GLAST; Glutamate transporter; Neuroprotection; Patch clamp; PKA

Indexed keywords

CYCLIC AMP DEPENDENT PROTEIN KINASE; ETOMIDATE; EXCITATORY AMINO ACID TRANSPORTER 1; EXCITATORY AMINO ACID TRANSPORTER 2; GLUTAMIC ACID;

AMINO ACID TRANSPORT; ANIMAL CELL; ARTICLE; CELL CULTURE; CONTROLLED STUDY; DRUG EFFECT; GLIA CELL; NEUROLOGIC DISEASE; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SPRAGUE DAWLEY RAT; SYNAPSE;

ANESTHETICS, INTRAVENOUS; ANIMALS; ANIMALS, NEWBORN; BRAIN; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; DOSE-RESPONSE RELATIONSHIP, DRUG; ETOMIDATE; GLUTAMIC ACID; NEUROGLIA; RATS; RATS, SPRAGUE-DAWLEY; TIME FACTORS;

EID: 57349126328     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/bjp.2008.336     Document Type: Article

References (57)

1. Adolph O, Köster S, Räth M, Georgieff M, Weigt HU, Engele J et al. (2007). Rapid increase of glial glutamate uptake via blockade of the protein kinase A pathway. Glia 55: 1699-1707.
2. Alexander SP, Mathie A, Peters JA (2008). Guide to Receptors and Channels (GRAC), 3rd edn. Br J Pharmacol 153 (Suppl 2): S1-S209.
3. Antkowiak B (2001). How do general anaesthetics work? Naturwissenschaften 88: 201-213.
4. Arriza JL, Fairman WA, Wadiche JI, Murdoch GH, Kavanaugh MP, Amara SG (1994). Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J Neurosci 14: 5559-5569.
5. Beart PM, O'Shea RD (2007). Transporters for L-glutamate: an update on their molecular pharmacology and pathological involvement. Br J Pharmacol 150: 5-17.
6. Buchholz RA, Dundore RL, Cumiskey WR, Harris AL, Silver PJ (1991). Protein kinase inhibitors and blood pressure control in spontaneously hypertensive rats. Hypertension 17: 91-100.
7. Carrick T, Dunlop J (1999). Protein kinase C modulation of the human excitatory amino acid transporter 2 subtype of glutamate transporter. Soc Neurosci Abstr 25: 426.
8. Casado M, Bendahan A, Zafra F, Danbolt NC, Aragon C, Gimenez C et al. (1993). Phosphorylation and modulation of brain glutamate transporters by protein kinase C. J Biol Chem 268: 27313-27317.
9. Casado M, Zafra F, Aragon C, Gimenez C (1991). Activation of high-affinity uptake of glutamate by phorbol esters in primary glial cell cultures. J Neurochem 57: 1185-1190.
10. Chen HS, Lipton SA (2005). Pharmacological implications of two distinct mechanisms of interaction of memantine with N-methyl-D- aspartate-gated channels. J Pharmacol Exp Ther 314: 961-971.
11. Cold GE, Eskesen V, Eriksen H, Blatt Lyon B (1986). Changes in CMRO2, EEG and concentration of etomidate in serum and brain tissue during craniotomy with continuous etomidate supplemented with N2O and fentanyl. Acta Anaesthesiol Scand 30: 159-163.
12. Conca A, Germann R, Konig P (2003). Etomidate vs thiopentone in electroconvulsive therapy. An interdisciplinary challenge for anesthesiology and psychiatry. Pharmacopsychiatry 36: 94-97.
13. Danbolt NC (2001). Glutamate uptake. Prog Neurobiol 65: 1-105.
14. Daniels KK, Vickroy TW (1999). Reversible activation of glutamate transport in rat brain glia by protein kinase C and an okadaic acid-sensitive phosphoprotein phosphatase. Neurochem Res 24: 1017-1025.
15. Do SH, Kamatchi GL, Washington JM, Zuo Z (2002). Effects of volatile anesthetics on glutamate transporter, excitatory amino acid transporter type 3: the role of protein kinase C. Anesthesiology 96: 1492-1497.
16. Doenicke AW, Roizen MF, Kugler J, Kroll H, Foss J, Ostwald P (1999). Reducing myoclonus after etomidate. Anesthesiology 90: 113-119.
17. Duan S, Anderson CM, Stein BA, Swanson RA (1999). Glutamate induces rapid upregulation of astrocyte glutamate transport and cell-surface expression of GLAST. J Neurosci 19: 10193-10200.
18. Engele J (1998). Spatial and temporal growth factor influences on developing midbrain dopaminergic neurons. J Neurosci Res 53: 405-414.
19. - currents via rat glutamate transporter EAAT4 by PMA. Am J Physiol Cell Physiol 290: C1334-C1340.
20. Figiel M, Engele J (2000). Pituitary adenylate cyclase-activating polypeptide (PACAP), a neuron-derived peptide regulating glial glutamate transport and metabolism. J Neurosci 20: 3596-3605.
21. Gancher S, Laxer KD, Krieger W (1984). Activation of epileptogenic activity by etomidate. Anesthesiology 61: 616-618.
22. Gegelashvili G, Civenni G, Racagni G, Danbolt NC, Schousboe I, Schousboe A (1996). Glutamate receptor agonists up-regulate glutamate transporter GLAST in astrocytes. Neuroreport 8: 261-265.
23. Gegelashvili G, Danbolt NC, Schousboe A (1997). Neuronal soluble factors differentially regulate the expression of the GLT1 and GLAST glutamate transporters in cultured astroglia. J Neurochem 69: 2612-2615.
24. Gonzalez MI, Kazanietz MG, Robinson MB (2002). Regulation of the neuronal glutamate transporter excitatory amino acid carrier-1 (EAAC1) by different protein kinase C subtypes. Mol Pharmacol 62: 901-910.
25. Gonzalez MI, Ortega A (1997). Regulation of the Na+-dependent high affinity glutamate/aspartate transporter in cultured Bergmann glia by phorbol esters. J Neurosci Res 50: 585-590.
26. Guillet BA, Velly LJ, Canolle B, Masmejean FM, Nieoullon AL, Pisano P (2005). Differential regulation by protein kinases of activity and cell surface expression of glutamate transporters in neuronenriched cultures. Neurochem Int 46: 337-346.
27. Hamil OP, Marty A, Neher E, Sakmann B, Sigworth FJ (1981). Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflügers Arch 391: 85-100.
28. Hediger MA (1999). Glutamate transporters in kidney and brain. Am J Physiol 277: F487-F492.
29. Howe AK (2004). Regulation of actin-based cell migration by cAMP/ PKA. Biochim Biophys Acta 1692: 159-174.
30. Khalil SN, Lawson KS, Hanis CL, Lemak NA, Ruiz RS (1999). Alfentanil decreases myoclonus caused by etomidate. Middle East J Anesthesiol 15: 185-192.
31. Kidd FL, Isaac JT (2000). Glutamate transport blockade has a differential effect on AMPA and NMDA receptor-mediated synaptic transmission in the developing barrel cortex. Neuropharmacology 39: 725-732.
32. Leonova J, Thorlin T, Aberg ND, Eriksson PS, Ronnback L, Hansson E (2001). Endothelin-1 decreases glutamate uptake in primary cultured rat astrocytes. Am J Physiol Cell Physiol 281: C1495-C1503.
33. Levron JC, Assoune P (1990). Pharmacokinetics of etomidate. Ann Fr Anesth Reanim 9: 123-126.
34. Little HJ (1996). How has molecular pharmacology contributed to our understanding of the mechanism(s) of general anesthesia? Pharmacol Ther 69: 37-58.
35. Lochner A, Moolman JA (2006). The many faces of H89: a review. Cardiovasc Drug Rev 24: 261-274.
36. McKhann II GM, D'Ambrosio R, Janigro D (1997). Heterogeneity of astrocyte resting membrane potentials and intercellular coupling revealed by whole-cell and gramicidin-perforated patch recordings from cultured neocortical and hippocampal slice astrocytes. J Neurosci 17: 6850-6863.
37. Meijer L (1995). Chemical inhibitors of cyclin-dependent kinases. Prog Cell Cycle Res 1: 351-363.
38. Meldrum BS (2000). Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J Nutr 130: 1007S-1015S.
39. Miyazaki H, Nakamura Y, Arai T, Kataoka K (1997). Increase of glutamate uptake in astrocytes: a possible mechanism of action of volatile anesthetics. Anesthesiology 86: 1359-1366.
40. Murphy TV, Prountzos C, Kotsonis P, Iannazzo L, Majewski H (1999). Structural determinants of phorbol ester binding in synaptosomes: pharmacokinetics and pharmacodynamics. Eur J Pharmacol 381: 77-84.
41. Proper EA, Hoogland G, Kappen SM, Jansen GH, Rensen MG, Schrama LH et al. (2002). Distribution of glutamate transporters in the hippocampus of patients with pharmaco-resistant temporal lobe epilepsy. Brain 125: 32-43.
42. Robinson MB (2002). Regulated trafficking of neurotransmitter transporters: common notes but different melodies. J Neurochem 80: 1-11.
43. Rothstein JD, Dykes-Hoberg M, Pardo CA, Bristol LA, Jin L, Kuncl RW et al. (1996). Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 16: 675-686.
44. +-dependent glutamate transporters by cyclic AMP analogs and neurons. Mol Pharmacol 53: 355-369.
45. Shimamoto K, Lebrun B, Yasuda-Kamatani Y, Sakaitani M, Shigeri Y, Yumoto N et al. (1998). DL-threo-beta-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters. Mol Pharmacol 53: 195-201.
46. Sims KD, Robinson MB (1999). Expression patterns and regulation of glutamate transporters in the developing and adult nervous system. Crit Rev Neurobiol 13: 169-197.
47. Sugimura M, Kitayama S, Morita K, Irifune M, Takarada T, Kawahara M et al. (2001). Effects of volatile and intravenous anesthetics on the uptake of GABA, glutamate and dopamine by their transporters heterologously expressed in COS cells and in rat brain synaptosomes. Toxicol Lett 123: 69-76.
48. Susarla BT, Seal RP, Zelenaia O, Watson DJ, Wolfe JH, Amara SG et al. (2004). Differential regulation of GLAST immunoreactivity and activity by protein kinase C: evidence for modification of amino and carboxyl termini. J Neurochem 91: 1151-1163.
49. +-dependent glutamate transporter: pharmacological characterization and lack of regulation by protein kinase C. J Pharmacol Exp Ther 289: 1600-1610.
50. Tian GF, Azmi H, Takano T, Xu Q, Peng W, Lin J et al. (2005). An astrocytic basis of epilepsy. Nat Med 11: 973-981.
51. Tong G, Jahr CE (1994). Block of glutamate transporters potentiates postsynaptic excitation. Neuron 13: 1195-1203.
52. Vandenberg RJ, Mitrovic AD, Chebib M, Balcar VJ, Johnston GA (1997). Contrasting modes of action of methylglutamate derivatives on the excitatory amino acid transporters, EAAT1 and EAAT2. Mol Pharmacol 51: 809-815.
53. Vermeiren C, Najimi M, Vanhoutte N, Tilleux S, de Hemptinne I, Maloteaux JM et al. (2005). Acute up-regulation of glutamate uptake mediated by mGluR5a in reactive astrocytes. J Neurochem 94: 405-416.
54. +/calmodulin- dependent protein kinase II. J Neurochem 56: 294-298.
55. Yun JY, Kim JH, Kim HK, Lim YJ, Do SH, Zuo Z (2006). Effects of intravenous anesthetics on the activity of glutamate transporter EAAT3 expressed in Xenopus oocytes: evidence for protein kinase C involvement. Eur J Pharmacol 531: 133-139.
56. Zelenaia O, Schlag BD, Gochenauer GE, Ganel R, Song W, Beesley JS et al. (2000). Epidermal growth factor receptor agonists increase expression of glutamate transporter GLT1 in astrocytes through pathways dependent on phosphatidylinositol 3-kinase and transcription factor NF-kappaB. Mol Pharmacol 57: 667-678.
57. Zuo Z (2001). Isoflurane enhances glutamate uptake via glutamate transporters in rat glial cells. Neuroreport 12: 1077-1080.